Log in to save to my catalogue

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9266727

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

About this item

Full title

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

Publisher

Basel: MDPI AG

Journal title

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7037

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Lung cancers are life-threatening malignancies that cause great healthcare burdens in Taiwan and worldwide. The 5-year survival rate for Taiwanese patients with lung cancer is approximately 29%, an unsatisfactorily low number that remains to be improved. We first reviewed the molecular epidemiology derived from a deep proteogenomic resource in Taiw...

Alternative Titles

Full title

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9266727

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9266727

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms23137037

How to access this item